The CD30 molecule exerts a regulator function on CD4+ but not on CD8+ T lymphocytes.10 It is possible that once this regulatory effect is lifted by the anti-CD30 neutralizing antibody, the unexpected autoreactivity of CD4+ T-cell population is unleashed leading to AKI from AIN. The gene discussed is CD4; the disease is acute kidney injury.